BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BIOTECanada - ECPv6.6.4.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.biotech.ca
X-WR-CALDESC:Events for BIOTECanada
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250407
DTEND;VALUE=DATE:20250409
DTSTAMP:20260422T091904
CREATED:20250307T161952Z
LAST-MODIFIED:20250312T164417Z
UID:10000452-1743984000-1744156799@www.biotech.ca
SUMMARY:Conscience Symposium on Open Drug Discovery
DESCRIPTION:Join a range of industry experts and informative sessions\, including a deeper dive into the most important issues and opportunities facing drug discovery and development\, the potential role that AI can play\, how competitions and benchmarking can drive the field\, and how new drug discovery business models are balancing open science and intellectual property. \nLearn more here and register now until April 2\, 2025
URL:https://www.biotech.ca/event/conscience-symposium-on-open-drug-discovery/
LOCATION:Montreal\, Canada
CATEGORIES:Non-member
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250410T120000
DTEND;TZID=America/Toronto:20250410T130000
DTSTAMP:20260422T091904
CREATED:20250319T192106Z
LAST-MODIFIED:20250319T192106Z
UID:10000453-1744286400-1744290000@www.biotech.ca
SUMMARY:Investing at the Frontier of Life Sciences Innovation [Webinar]
DESCRIPTION:AI-driven breakthroughs are accelerating drug discovery\, transforming diagnostics\, and pushing the boundaries of precision medicine. Quantum computing is advancing toward commercialization\, with the potential to reshape molecular modeling and therapeutic development. Canada has the research leadership\, deep technology capabilities\, and growing private capital interest to turn these advancements into global competitive advantages—but the question is how investors can position themselves to capture the upside. \nThis webinar\, presented in partnership with BIOTECanada\, brings together leading investors to explore where innovation and technology have already generated returns in life sciences\, how biotech investment models are evolving\, and what private capital needs to do now to stay ahead of the next wave of disruption. With drug development cycles shortening\, computational breakthroughs unlocking new IP\, and a shift from one-drug companies to biotech platforms\, this discussion will focus on the real investment opportunities that will define the next decade of life sciences. \nRegister Here \nThe webinar is free for everyone\, will be live-streamed on our LinkedIn and also available to watch after on our website.
URL:https://www.biotech.ca/event/investing-at-the-frontier-of-life-sciences-innovation/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250411T140000
DTEND;TZID=America/Toronto:20250411T150000
DTSTAMP:20260422T091904
CREATED:20250328T135127Z
LAST-MODIFIED:20250328T135127Z
UID:10000455-1744380000-1744383600@www.biotech.ca
SUMMARY:Webinar: Polysialic acid is associated with T cell activation and controls migration
DESCRIPTION:Dr. Lisa Willis and her research team at the University of Alberta explore how polysialic acid influences T cell biology. Their research highlights the glycan’s crucial role in the migration of antigen-experienced T cells\, offering new insights into T cell activation and potential therapeutic strategies for chronic diseases.
URL:https://www.biotech.ca/event/webinar-polysialic-acid-is-associated-with-t-cell-activation-and-controls-migration/
LOCATION:Webinar
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250430T133000
DTEND;TZID=America/Toronto:20250430T163000
DTSTAMP:20260422T091904
CREATED:20250416T170336Z
LAST-MODIFIED:20250416T175703Z
UID:10000459-1746019800-1746030600@www.biotech.ca
SUMMARY:SCI Sustainable Innovation and Industry Event – 30 April 2025
DESCRIPTION:Line up of speakers: \n\nDr Ravi Ramachandran\, Syngenta\, Canada\nTara McCaughey – Head of Technology Solutions and Sustainable Agriculture at Syngenta Canada\nCara Eaton – Global Sustainability Director – at CRODA Consumer Care\, USA\nDr Mike Irwin – Senior Vice President\, Advanced Product and Chemical Technology at Woodbridge Foam Corporation\nSharon Todd – CEO SCI\, UK\n\nJoin a team of global Industry experts to discuss the opportunities and challenges organizations face to meet sustainability goals whilst maintaining a profitable business. Learn how top executives are tackling supply chain issues to reduce the carbon footprint of their operations\, sourcing sustainable raw materials\, establishing science-based target measurements\, and helping their customers achieve sustainable outcomes. \nThis a unique opportunity for stakeholders to attend and meet with industry leaders from around the world (US\, Europe and Canada) and learn about industry perspectives on sustainable innovation opportunities and the challenges of addressing regulatory and customer \nSCI Awards Dinner 2025 – 30 April 2025 \nChelsea Hotel\, Toronto \n18:00 – 22:30 \nThis event will precede the prestigious SCI Canada Awards celebrating excellence in science and industry. The Awards showcase talent and innovation within the sector. Spaces for the Awards are limited. However\, there is still opportunity to secure your table/seat or sponsor the Industry event or seminar. \nCost per table of 10 $2\,100 \nHalf-table of 5 $1\,050 \nIndividual seat $210  \n(All seats include networking reception and 3-course dinner with wine/soft drinks) \nFor more information on the Awards or sponsorship opportunities\, click here: SCI Canada Awards 2025  or email SCIcanada@soci.org
URL:https://www.biotech.ca/event/sci-sustainable-innovation-and-industry-event-30-april-2025/
LOCATION:Chelsea Hotel\, Toronto
CATEGORIES:Non-member
END:VEVENT
END:VCALENDAR